PEPTIDE SYNTHESIS, OLIGOMER PREPARATION AND CONFORMATION-DEPENDENT ANTIBODY CORE
PEPTIDE SYNTHESIS, OLIGOMER PREPARATION AND CONFORMATION-DEPENDENT ANTIBODY CORE
批准号:
8224269
负责人:
MATHIAS LOSECHE
金额:
$5.72万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2012-06-30
关键词:
Amino Acid SequenceAmyloidAmyloid FibrilsAmyloid beta-ProteinAntibodiesAtomic Force MicroscopyCaliberCellsCommon EpitopeDegenerative DisorderDiseaseElectronsEpitopesGeneric DrugsGoalsIn VitroIndiumMediatingMembraneMolecular ConformationPathogenesisPeptide SynthesisPeptidesPreparationProteinsReagentResearch Project GrantsRoleStructureToxic effectVertebral columnbaseconformational conversionmonomerpolypeptideprogramsprotein foldingresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Even though there is compelling evidence for a causal role of amyloid forming proteins in disease, the type
of amyloid and its assembly state is controversial and remains to be established. Prefibrillar amyloid oli-
gomers are soluble spherical aggregates of approximately 3-10 nm in diameter that have been observed for
many different types of amyloids by electron and atomic force microscopy. One of the significant advances in
our understanding of prefibrillar oligomers was the finding that amyloid oligomers have a common peptide
backbone structure that is distinct from amyloid fibrils based on the observation that a conformation depend-
ent antibody specifically recognizes a common epitope on amyloid oligomers, but not fibrils, monomers or
natively folded proteins for many different types of proteins. This indicates that the antibody recognizes a ge-
neric polypeptide backbone epitope that is independent of the amino acid sequence, but yet is shared in
common among all types of amyloid oligomers. The anti-oligomer antibody also generically inhibits the toxic-
ity of soluble oligomers examined in vitro. Since different amyloid oligomers share a common structure and
they are generically toxic to cells regardless of what protein they are derived from, this suggests that they
have the same primary mechanism of toxicity in degenerative diseases. A growing body of evidence sug-
gests that membrane permeabilization by amyloid oligomers may represent the common, primary mecha-
nism of pathogenesis of amyloid related degenerative diseases.
The overall goal of this program project is to elucidate the mechanism of membrane permeabilization by
amyloid prefibrillar oligomers. I support of the specific aims of the projects, Core C will provide homogene-
ous preparations of prefibrillar Aft oligomers to the projects as well as fluorescent and deuterated Aftoli-
gomers. Core C will also provide preparations of alternative assembly states, such as amyloid fibrils and an-
nular protofibrils as controls. Core C also provides conformation dependent antibodies that specifically rec-
ognize prefibrillar oligomers, fibrils and annular protofibrils for use in blocking membrane permeabilization
and verifying the conformational status of the oligomer preparations during and after the experiments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PEPTIDE SYNTHESIS, OLIGOMER PREPARATION AND CONFORMATION-DEPENDENT ANTIBODY CORE
-
批准号:7582770
-
项目类别:
-
资助金额:$8.35万
-
财政年份:2009
-
负责人:MATHIAS LOSECHE
-
依托单位:
PEPTIDE SYNTHESIS, OLIGOMER PREPARATION AND CONFORMATION-DEPENDENT ANTIBODY CORE
-
批准号:8020068
-
项目类别:
-
资助金额:$6.45万
-
财政年份:--
-
负责人:MATHIAS LOSECHE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
-
批准号:22077118
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2020
-
负责人:高楠
-
依托单位:
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
-
批准号:81870666
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:王海燕
-
依托单位:
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
-
批准号:81601123
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:都瑾
-
依托单位:
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
-
批准号:30971012
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2009
-
负责人:刘瑞田
-
依托单位:
抗阿兹海默病Beta-Amyloid寡聚物单链可变区抗体的筛选及其动物试验
-
批准号:30570622
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2005
-
负责人:刘瑞田
-
依托单位: